Athira Pharma, Inc.

Dec 09, 2019

Athira Pharma Presents Positive Data for NDX-1017 in Alzheimer's Patients at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference

Nov 20, 2019

Athira Pharma to Present Phase 1 Data for NDX-1017 in Oral Presentation at 2019 Clinical Trials on Alzheimer's Disease (CTAD) Conference

Oct 02, 2019

Athira Pharma Announces Completion of Phase 1b Clinical Trial of NDX-1017 in Alzheimer's Patients

Jul 11, 2019

Athira Pharma Announces Appointment of Mark Litton as Chief Operating Officer

Jul 01, 2019

Athira Pharma's Leen Kawas Selected as Young Leader by French-American Foundation

May 01, 2019

Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer

Apr 11, 2019

M3 Biotechnology Announces Name Change to Athira Pharma, Inc.